Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rennova Health Inc (OTCQB:RNVA)

0.1301
Delayed Data
As of 10:39am ET
 -0.01 / -7.14%
Today’s Change
0.11
Today|||52-Week Range
103.50
-99.65%
Year-to-Date
SECTOR
Electronic Technology
INDUSTRY
Electronic Production Equipment
MARKET CAP
$190.4K

Company Description

Rennova Health, Inc. engages in provision of diagnostics and supportive software solutions to healthcare providers. It operates through the following segments: Clinical Laboratory Operations; Supportive Software Solutions; and Decision Support Informatics. The Clinical Laboratory Operations segment provides urine drug toxicology testing to physicians, clinics, and rehabilitation facilities. The Supportive Software Solutions segment offers a customizable Electronic Health Record (EHR) and revenue cycle management services providing a full suite of billing services to substance abuse and behavioral health providers, as well as a dictation-based ambulatory EHR for physician practices and advanced transcription services. The Decision Support and Informatics segment develops and markets medical information and clinical decision support products and services intended to set a standard for the clinical interpretation of genomics-based, precision medicine. The company was founded in December 1989 and is headquartered in West Palm Beach, FL.

Contact Information

Rennova Health, Inc.
400 South Australian Avenue
West Palm Beach Florida 33401
P:(561) 855-1626
Investor Relations:
(156) 166-6818

Employees

Shareholders

Other institutional9.49%
Mutual fund holders0.08%
Individual stakeholders--

Top Executives

Seamus LaganPresident, Chief Executive Officer & Director
Sebastien SainsburyHead-Investment Development & Public Relations
Karen TaylorDirector-Human Resources
Victoria NemersonGeneral Counsel